Protirelin
Also known as: TRH, Thyrotropin-releasing hormone
Protirelin is a synthetic form of thyrotropin-releasing hormone (TRH) that stimulates the release of thyroid-stimulating hormone from the anterior pituitary. This tripeptide hormone plays a central role in thyroid function regulation and serves as a diagnostic tool for evaluating thyroid and pituitary disorders.
Protirelin is a 362.39 g/mol research peptide. Protirelin is a synthetic form of thyrotropin-releasing hormone (TRH) that stimulates the release of thyroid-stimulating hormone from the anterior pituitary. This tripeptide hormone plays a central role in thyroid function regulation and serves as a diagnostic tool for evaluating thyroid and pituitary disorders.
Also called: TRH, Thyrotropin-releasing hormone
362.39 g/mol
Molecular Weight
Daltons
3
Strong Evidence
benefits
4
Studies Cited
peer-reviewed
200-500
Typical Dose
mcg
Overview
Protirelin functions as the synthetic analog of the naturally occurring hypothalamic hormone TRH. The peptide triggers the release of both thyroid-stimulating hormone (TSH) and prolactin from the anterior pituitary gland through its action on specific G-protein coupled receptors. In clinical settings, protirelin administration provides valuable diagnostic information about thyroid axis function, helping differentiate between primary thyroid disorders and secondary hypothyroidism caused by pituitary dysfunction. The hormone's rapid onset of action and predictable response patterns make it particularly useful for research applications examining thyroid regulation mechanisms and metabolic responses to acute TSH elevation.
Key Takeaways: Protirelin
- Strongest evidence supports Protirelin for thyroid function assessment and pituitary dysfunction diagnosis
- Research doses typically range from 200 to 500 mcg via iv
- 3 benefits with strong evidence, 2 moderate, 1 preliminary
- Half-life: 2-5 minutes
- 4 cited research studies in this guide
Mechanism of Action
Protirelin binds to TRH receptors on thyrotroph cells in the anterior pituitary gland, activating phospholipase C through Gq/11 protein coupling. This activation increases intracellular calcium and protein kinase C activity, leading to rapid degranulation and release of stored TSH. The released TSH then stimulates thyroid follicular cells to produce and secrete thyroid hormones T3 and T4. Protirelin also acts on lactotroph cells to stimulate prolactin release through similar receptor mechanisms.
Research Benefits
Protirelin at a Glance
Protirelin binds to TRH receptors on thyrotroph cells in the anterior pituitary gland, activating phospholipase C through Gq/11 protein coupling.
Thyroid Function Assessment
Strong EvidenceProtirelin provides precise evaluation of pituitary TSH reserve and thyroid axis integrity, with normal individuals showing 2-5 fold TSH increases within 15-30 minutes of administration.
Pituitary Dysfunction Diagnosis
Strong EvidenceDistinguishes between primary thyroid disease and secondary hypothyroidism by revealing impaired TSH responses in cases of pituitary insufficiency or hypothalamic dysfunction.
Prolactin Response Testing
Strong EvidenceEvaluates lactotroph cell function through consistent prolactin release, helping assess pituitary adenomas and hyperprolactinemia causes.
Growth Hormone Release
Moderate EvidenceStimulates growth hormone secretion in some individuals, particularly those with acromegaly or growth hormone excess, providing diagnostic information about somatotroph function.
Metabolic Rate Modulation
Moderate EvidenceAcutely increases metabolic rate through TSH-mediated thyroid hormone release, useful for studying short-term metabolic responses and thermogenesis.
Central Nervous System Effects
PreliminaryProduces mild CNS stimulation and arousal effects, contributing to research on hypothalamic-pituitary neural pathways and neurotransmitter interactions.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| TSH stimulation test | 200–500 mcg | IV |
| Prolactin response | 200–400 mcg | IV |
| Growth hormone testing | 200–500 mcg | IV |
Frequency
Single dose for testing protocols
Timing
Morning administration preferred for baseline hormone measurements
Research Notes
- 1Blood samples typically drawn at 0, 15, 30, and 60 minutes post-injection
- 2Subjects should fast for 8-12 hours prior to testing
- 3Baseline TSH and prolactin levels measured before administration
- 4Response magnitude varies with age, sex, and thyroid status
Reconstitution Guide
Standard Reconstitution
Vial Size
500 mg
Bacteriostatic Water
2 mL
Concentration
2500 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
Protirelin vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 2 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C. 24 hours after reconstitution.
Storage Temperature
2-8°C
Shelf Life
24 hours after reconstitution
Important Notes
- •Use sterile water for injection or normal saline
- •Gentle mixing required to avoid foaming
- •Solution should be clear and colorless
- •Single use vials - discard after use
Protirelin Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
Protirelin Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Transient nausea and urge to urinate
- !Mild flushing and warmth sensation
- !Metallic taste in mouth
- !Slight blood pressure changes
- !Abdominal cramping
- !Headache and dizziness
- !Breast tenderness (due to prolactin release)
- !Anxiety or restlessness
- !Palpitations from increased heart rate
Potential Interactions
- ⚡Thyroid hormones may blunt TSH response
- ⚡Dopamine agonists reduce prolactin response to protirelin
- ⚡Glucocorticoids can suppress both TSH and prolactin release
- ⚡Somatostatin analogs may inhibit growth hormone response
- ⚡Phenothiazines may enhance prolactin response
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
The TRH stimulation test in the diagnosis of mild hyperthyroidism
Demonstrated that protirelin testing can detect subtle thyroid dysfunction not apparent from baseline hormone measurements, with suppressed TSH responses indicating hyperthyroid states.
Prolactin and growth hormone responses to thyrotropin-releasing hormone in normal subjects
Established normal response patterns for both prolactin and growth hormone following protirelin administration, showing consistent prolactin increases but variable growth hormone responses.
TRH test in the diagnosis of thyroid disease
Comprehensive analysis of protirelin testing utility in various thyroid conditions, confirming its value for differentiating primary from secondary hypothyroidism.
Age and sex differences in response to thyrotropin-releasing hormone
Found that TSH response to protirelin varies significantly with age and gender, with older individuals showing blunted responses and women generally exhibiting greater prolactin increases.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
TSH levels typically peak 15-30 minutes after protirelin injection, with prolactin responses occurring within the same timeframe. Effects return to baseline within 2-3 hours.
Normal individuals show a 2-5 fold increase in TSH levels, typically rising from baseline to 6-30 mIU/L depending on starting levels and individual sensitivity.
No, protirelin is purely diagnostic and not therapeutic. While it stimulates TSH release, the effect is temporary and does not provide sustained thyroid hormone improvement.
Protirelin testing is generally avoided during pregnancy unless absolutely necessary, as hormonal changes can affect interpretation of results and safety data is limited.
Protirelin is chemically identical to natural TRH but produced synthetically. It has the same biological activity and receptor binding properties as endogenous hormone.
Thyroid hormones, dopamine agonists, and corticosteroids can significantly alter responses. These should be discontinued when possible before testing, following appropriate washout periods.
The nausea results from rapid hormone release and subsequent physiological changes, including altered gastric motility and possible direct effects on chemoreceptor trigger zones.
Protirelin testing can reveal abnormal hormone responses that suggest pituitary dysfunction, but imaging studies are required for definitive tumor diagnosis and localization.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.